''The impact on section 3(d) on Indian Pharmaceutical industry

More about the book

Focusing on the intersection of research and development within the Indian pharmaceutical industry, the book explores the implications of section 3(d) of Indian Patent law. It analyzes how this legislation affects both the economic realities of impoverished patients and the domestic pharmaceutical sector. The author advocates for a more flexible interpretation of this law, drawing on recommendations from the Mashelkar Committee. While not exhaustive, the work aims to provide a clear understanding of these critical issues in the context of resource creation and knowledge in business.